SCHEMBL29405394

SCHEMBL29405394

COc1ccc(-n2cc(C)nn2)c(CNC(=O)c2cn(Cc3cc4n(n3)CCN(C)C4)nc2C(F)F)c1F

nearest known ligand 0.83

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 13/20 0.83
▸ F11 P03951 8/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22982146 1.00 KLKB1 (0.83) KLKB1F11
SCHEMBL29407571 0.91 KLKB1 (0.83) KLKB1F11
SCHEMBL22982147 0.87 F11 (1.00) KLKB1F11
SCHEMBL29405871 0.84 F11 (0.83) KLKB1F11
SCHEMBL22981539 0.82 F11 (1.00) KLKB1F11
SCHEMBL29407558 0.82 F11 (1.00) KLKB1F11
SCHEMBL29407062 0.75 KLKB1 (1.00) KLKB1F11
SCHEMBL29407401 0.75 KLKB1 (1.00) KLKB1F11
SCHEMBL22981868 0.75 KLKB1 (1.00) KLKB1F11
SCHEMBL22981502 0.75 F11 (0.85) KLKB1F11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010333-A1 PLASMA KALLIKREIN INHIBITORS Kalvista Pharmaceuticals Limited (GB) 2022-06-15 — — EP claimed
CN-114206852-A Plasma kallikrein inhibitors 卡尔维斯塔制药有限公司 2022-03-18 — — CN claimed
EP-4010333-A1 PLASMA KALLIKREIN INHIBITORS Kalvista Pharmaceuticals Limited (GB) 2022-06-15 — — EP disclosed
CN-114206852-A Plasma kallikrein inhibitors 卡尔维斯塔制药有限公司 2022-03-18 — — CN disclosed
Send feedback